MREO stock

Mereo BioPharma Group PLC ADR (MREO) financials · rev $500.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Mereo BioPharma Group PLC ADR (MREO) rev $500.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$500.0KN/A
Operating Income-$40.1M-$47.4M
Net Income-$41.9M-$43.3M
EPS (Diluted)-$0.05-$0.06
Cached annual balance sheet
LineFY2025FY2024
Total Assets$45.9M$76.4M
Current Assets$45.0M$74.8M
Cash & Equivalents$41.0M$69.8M
PP&E$137.0K$257.0K
Total Liabilities$5.00M$15.4M
Current Liabilities$4.30M$13.8M
Shareholders' Equity$40.9M$61.0M
Retained Earnings-$501.0M-$462.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$31.0M-$32.8M
CapEx$20.0KN/A
Investing Cash Flow-$20.0K-$699.0K
Financing Cash Flow$327.0K$46.1M
Net Change in CashN/A$12.4M
Free Cash Flow-$31.0M-$32.8M
These statements as JSON? API free 100/day

FAQ

What is MREO P/E and revenue?

Mereo BioPharma Group PLC ADR (MREO) rev $500.0K.

What is MREO revenue?

Mereo BioPharma Group PLC ADR last cached revenue is $500.0K (FY2025).

Is MREO profitable?

Mereo BioPharma Group PLC ADR last cached net income is -$41.9M (FY2025).

What are MREO total assets?

Mereo BioPharma Group PLC ADR last cached total assets are $45.9M (FY2025).

What is MREO free cash flow?

Mereo BioPharma Group PLC ADR last cached free cash flow is -$31.0M (FY2025).

Not investment advice. Cached statements, not a live tape.